The global CAR T-cell therapy market is witnessing substantial growth over the forecast period of 2023 to 2028. This growth can be attributed to a number of factors, including rising prevalence of cancer, developments in cell therapy technology, and positive regulatory sentiments. The market is also stimulated by a increasing demand for advanced ca